TITLE

PCP PREVENTION ALERT

AUTHOR(S)
Delaney, Martin
PUB. DATE
November 1991
SOURCE
Advocate;11/19/91, Issue 590, p37
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports on the medical alert received by physicians from the U.S. National Institutes of Health concerning the prevention of second bouts of Pneumocystis carinii pneumonia. Call for monthly treatments with aerosol pentamidine; Superiority of the oral use of two common antibiotics.
ACCESSION #
9704435

 

Related Articles

  • Pneumocystis carinii pneumonia.  // Modern Medicine;Aug95, Vol. 63 Issue 8, p26 

    Reports on the US Food and Drug Administration's approval on the marketing of a suspension form of atovaquone in the treatment of pneumocystis carinii pneumonia. Advantages and convenience; Dosage.

  • Current management practices in the treatment of Pneumocystis carinii pneumonia (PCP). Blanchet, Kevin D. // AIDS Patient Care & STDs;Apr96, Vol. 10 Issue 2, p116 

    Presents a dialogue on current management practices in the treatment of Pneumocystis carinii pneumonia (PCP). Prophylaxis and compliance; Treatment of mild PCP; Patient management issues.

  • Pneumocystis carinii pneumonia prophylaxis reduces mortality, costs.  // Formulary;Sep95, Vol. 30 Issue 9, p544 

    Presents an abstract of the article `The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia,' by J.E. Gallant, S.M. McAvinue, R.D. Moore et al, which appeared in the 1995 issue of `Chest' periodical.

  • RACE AND TREATMENT ACCESS.  // Advocate;6/28/94, Issue 658, p58 

    Reports on racial disparities in the administration of antiretroviral therapy and prophylactic treatment for Pneumocystis carinii pneumonia. Access to and standards of care.

  • Improved Treatment For Pneumocystis. Helquist, Michael // Advocate;10/13/87, Issue 483, p23 

    Reports on the efficacy of aerosol pentamidine against pneumocystis carinii pneumonia in persons with AIDS. Absence of side effects; Reduction in average hospital stay.

  • DELAYING THE ONSET OF ILLNESS. Cohan, Gary R. // Advocate;2/8/94, Issue 648, p34 

    Reports that prophylaxis against Pneumocystis carinnii infection may delay the onset of the first AIDS-related illness.

  • Prophylaxis Recommendations for Pneumocystis. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;3/25/2002, Vol. 15 Issue 3, p110 

    Reports the indication of primary prophylaxis of Pneumocystis for patients with history of Pneumocystis carinii pneumonia. Efficacy of trimethoprim-sulfamethoxazole (TMP-SMX); Considerations in discontinuing primary and secondary prophylaxis; Dosage for TMP-SMX.

  • Prophylaxis Failure Is Associated with a Specific Pneumocystis carinii Genotype. Hauser, Philippe M.; Sudre, Philippe; Nahimana, Aimable; Francioli, Patrick // Clinical Infectious Diseases;10/1/2001, Vol. 33 Issue 7, p1080 

    To investigate the possible association between Pneumocystis carinii types and various clinical and demographic parameters, we used molecular typing to analyze 93 bronchoalveolar lavage specimens from patients with P. carinii pneumonia (PCP). Multivariate regression analysis revealed an...

  • Trimetrexate glucuronate (NeuTrexin).  // RN;May94, Vol. 57 Issue 5, p55 

    Presents information on the anti-Pneumocystis carini pneumonia (PCP) drug Trimetrexate glucuronate by U.S. Bioscience. Description, indications and contraindications; Dosage and administration; Adverse reactions; Drug interactions; Pregnancy and nursing mothers; Pediatric use; Patient counseling.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics